Valuation: Celularity Inc.

Market Cap 22.58M 19.86M 18.45M 16.97M 31.82M 2.19B 32.39M 221M 86.04M 1.07B 84.76M 82.93M 3.7B P/E 2024
-0.79x
P/E 2025 -0.31x
Enterprise Value 91.12M 80.14M 74.45M 68.47M 128M 8.82B 131M 890M 347M 4.3B 342M 335M 14.93B EV / Sales 2024
2.12x
EV / Sales 2025 3.77x
Free-Float
62.82%
Yield 2024 *
-
Yield 2025 -
1 day+1.92%
1 week+1.87%
Current month+30.87%
1 month+11.82%
3 months-30.13%
6 months-39.34%
Current year-29.50%
1 week 0.75
Extreme 0.75
0.84
1 month 0.56
Extreme 0.5601
0.86
Current year 0.56
Extreme 0.5601
1.51
1 year 0.56
Extreme 0.5601
4.31
3 years 0.56
Extreme 0.5601
7.97
5 years 0.56
Extreme 0.5601
131.86
10 years 0.56
Extreme 0.5601
134
Manager TitleAgeSince
Chief Executive Officer 66 01/01/2016
Director of Finance/CFO 67 27/02/2026
Compliance Officer 42 01/07/2021
Director TitleAgeSince
Chairman 66 01/01/2016
Director/Board Member 64 01/07/2017
Director/Board Member 73 03/06/2022
Date Insider Type Main position Quantity % Market Cap.
19/06/26 Other 2,043,979 7.0614%
19/06/26 Other 2,043,979 7.0614%
19/06/26 Other 2,043,979 7.0614%
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%+1.87%-78.20%-84.75% 22.58M
+0.04%-3.95%+13.93%-10.31% 66.25B
-0.12%+2.23%+36.63%+198.45% 52.86B
+0.51%+37.90%+37.90%+37.90% 43.01B
-1.86%-4.93%-56.15%-56.66% 39.52B
+2.10%-3.01%+54.70%-26.85% 29.19B
+0.28%+0.03%+65.07%+83.87% 23.13B
-1.60%-9.70%+64.48%-53.64% 23.04B
-1.30%-6.18%+3.94%+177.59% 20.48B
-1.04%-1.59%+66.57%+124.27% 16.6B
Average +0.01%-1.90%+20.89%+38.99% 31.41B
Weighted average by Cap. -0.16%-1.59%+25.60%+47.17%

Financials

2024 2025
Net sales 54.22M 47.69M 44.3M 40.74M 76.41M 5.25B 77.78M 530M 207M 2.56B 204M 199M 8.89B 26.55M 23.35M 21.69M 19.95M 37.42M 2.57B 38.09M 259M 101M 1.25B 99.67M 97.52M 4.35B
Net income -57.89M -50.92M -47.3M -43.5M -81.58M -5.61B -83.05M -566M -221M -2.73B -217M -213M -9.49B -91.72M -80.66M -74.94M -68.92M -129M -8.88B -132M -896M -350M -4.33B -344M -337M -15.03B
Net Debt 68.1M 59.89M 55.64M 51.17M 95.97M 6.59B 97.69M 665M 260M 3.22B 256M 250M 11.16B 68.54M 60.28M 56M 51.5M 96.59M 6.64B 98.32M 670M 261M 3.24B 257M 252M 11.23B
Logo Celularity Inc.
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. Its IMPACT manufacturing platform is a fully integrated process designed to optimize the speed of the sourcing of placentas from full-term healthy informed consent donors through the use of proprietary processing methods, cell selection, product-specific chemistry, manufacturing and control (CMC), advanced cell manufacturing and cryopreservation. It also provides contract manufacturing and development services to third parties.
Employees
115
Date Price Change Volume
23/07/26 $0.7825 +0.32% 19,431
22/07/26 $0.7800 -3.70% 21,464
21/07/26 $0.8100 +3.85% 11,904
20/07/26 $0.7800 -0.04% 7,610
17/07/26 $0.7803 +1.59% 16,925

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CELU Stock